USPTO 2015–2025 USPTO PatentsView US Corporation

Cytori Therapeutics, Inc.

USPTO PatentsView assignee record - 13 granted patents across 7 technology areas, recorded in grant years 2015–2018. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

The verdict

According to USPTO PatentsView, Cytori ranks #20,982 of 50,000 tracked US assignees by granted-patent volume, with 13 patents across 7 technology areas.

#20,982
of 50,000 US assignees by volume
Top 61%
by Innovation Score (31.9/100)
22.5
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20982 · US Corporation #20,982 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 13 grants
  • MID-PACK #20,982/50,000
  • PHOTO-FINISH California Eastern L…
  • CPC-NARROW C12N · 7 areas
  • INNOV-THIN 31.9/100
  • CLAIMS-DENSE 22.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: California Eastern Laboratories, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Cytori

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Cytori's Innovation Score is 31.9/100 (top 61% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Cytori's grants concentrate

Cytori Therapeutics, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). Peak complete grant year is 2016 (8 grants) versus a trough of 1 in 2015. By volume, Cytori sits between Crystal Lagoons (curacao) B.v. and Careband, Inc..

Who files at Cytori's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Cytori holds 13 patents at rank #20,928, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Cytori

By rank, the assignees closest to #20,928 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Cytori's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Cytori, neither rank-band nor same-CPC leaders (those blocks stay above).

Cytori's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 Top 61% higher than 39% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 2015201620172018 2
USPTO utility patent grants by year · 2015–2018

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Cytori Therapeutics, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 7.7%
2016 8 61.5%
2017 2 15.4%
2018 2 15.4%

Where it ranks

Overall rank by patents

#20,982

of 50,000 tracked assignees

Innovation Score

31.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.